Conquer Bladder Cancer Today
EMDA THAILAND (ELECTROMOTIVE DRUG ADMINISTRATION) – Electro Motive Drug Administration is Imported in Thailand by Galileox Medical as License Holder of Physion SRL, Italy. Superior drug penetration for Non-Muscle Invasive Bladder Cancer and Functional Urological Disorders
Our Studies and Researches
Bladder Cancer Treatment Improvements with EMDA
Chemotherapy for Bladder Cancer with EMDA
Proven deeper tissue penetration of Mytomicin with EMDA® compared to passive administration.
Traditional Therapy
Traditional Therapy without EMDA
EMDA Enhanced Terapy
Theraphy when EMDA is activated
EMDA® is a unique technology to augment the effect of intravesical chemotherapy by creating an electric field across the bladder wall which increases urothelium’s permeability.
The Physion EMDA® system has been proved excellent results in treating high-risk and intermediate-risk patients with non-muscle invasive bladder cancer.
EMDA® + Mitomycin treatment is an efficacy tool in the long term conservative strategy of high-risk unresponsive to BCG as a “bladder sparing” therapy.
Several thousand treatment cycles have been performed with complete safety following TURBT: significantly reduced recurrence and progression with increased disease-free interval.
Bladder Cancer Treatments
Standard procedure
per session
A urogenic 16F electrode-catheter is inserted into the bladder
The bladder is drained to remove residual electrolytes
The drug solution is administered
Two dispersive electrodes are placed on the sides of the navel with an abundante layer of conductive gel
A micro-current is applied for 20 minutes
Get in touch
Send us a message and we'll get back to you as soon as we can.